位置：成果数据库 > 期刊 > 期刊详情页
Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mit
  • 期刊名称：Biomaterials
  • 时间：2013.2.11
  • 页码：3366-3380
  • 相关项目：肿瘤凋亡基因靶向性抗耐药脂质体的构建及其作用机制研究
作者： Ju RJ|Li XY|Zhao WY|Lu WL|
同期刊论文项目
肿瘤凋亡基因靶向性抗耐药脂质体的构建及其作用机制研究
期刊论文 15
同项目期刊论文
Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapse
Liposomes, modified with PTD (HIV-1) peptide, containing epirubicin and celecoxib, to target vasculo
Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targetin
The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leu
The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in r
A Combination of Targeted Sunitinib Liposomes and Targeted Vinorelbine Liposomes for Treating Invasi
Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin
Targeting epirubicin plus quinacrine liposomes modified with DSPE-PEG2000-C(RGDfK) conjugate forelim
Advances in investigations on the mechanism of cancer multidrug resistance and the liposome
Targeting drug delivery systems for circumventing multidrug resistance of cancers
A Combination of Targeted Sunitinib Liposomes and Targeted Vinorelbine Liposomesfor Treating Invasiv
The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene gl
Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inh
复方表阿霉素奎宁注射剂对耐药乳腺癌的治疗效应与机制研究